RS

RS Offers an Extensive Portfolio of Industrial MRO Solutions That Empower Proactive Maintenance Programs

Retrieved on: 
Tuesday, June 13, 2023
Lighting, Industrial internet of things, LSE, Maintenance, Renewable energy, RS Group, Engineering, Fourth Industrial Revolution, RS, RS Group plc, Growth, Goodyear Tire and Rubber Company, Transport, MRO, Automation, Risk management, Maintenance (technical)

FORT WORTH, Texas, June 13, 2023 /PRNewswire/ -- RS, a trading brand of RS Group plc (LSE: RS1), a global provider of industrial product and service solutions, provides plant managers, engineers, maintainers, and procurement professionals with game-changing technologies and engineering solutions that empower valuable predictive and preventative maintenance programs.

Key Points: 
  • RS has the MRO expertise, trusted brands, and in-stock products necessary to empower proactive maintenance programs.
  • RS also has access to the MRO industry's most trusted industrial brands, as well as an abundance of proactive maintenance solutions in stock and ready to ship.
  • The RS portfolio of MRO solutions for the manufacturing industry includes:
    Industrial V-belts from Goodyear Belts , a division of the world-renowned Goodyear Tire Rubber Company.
  • For more information about the RS portfolio of MRO solutions , including RS Expert Advice articles, interviews, and podcasts about maintenance , repair , and operations , please click the links embedded here.

Keros Therapeutics Presents Clinical Trial and Preclinical Study Results from its KER-050 Program and Preclinical Data from its ALK2 Inhibitor Program at the 28th Annual Congress of the European Hematology Association

Retrieved on: 
Friday, June 9, 2023
NT, Red blood cell, Cohort, Bone marrow, Patient, Iron, Male, Nosebleed, Transferrin, Fatigue, Diet, Myocardial infarction, Diarrhea, TI, HTB, Adenine, Research, Injection site reaction, Hematology, Heart, Chronic kidney disease, Solar cycle 1, COVID-19, Hematologic disease, Transfusion-dependent anemia, IWG, Biomarker, Acute myeloid leukemia, Erythropoiesis, Spleen, Anemia, Iron overload, ALK2, Therapy, Haematopoiesis, RBC, Ruxolitinib, European Hematology Association, LTB, Hematocrit, Part, Inflammation, MDS, Chronic obstructive pulmonary disease, EHA, RS, Nausea, Periodic breathing, Mouse, AI, CKD, KROS, Pharmaceutical industry, Dietary supplement, Medical device, Medical imaging, Silviculture, Residential care, Copper, Palladium, MF

In addition, Keros announced preclinical data evaluating activin receptor-like kinase-2 (“ALK2”) inhibition, as well as its combination with RKER-050, as potential treatment options for anemia of inflammation.

Key Points: 
  • In addition, Keros announced preclinical data evaluating activin receptor-like kinase-2 (“ALK2”) inhibition, as well as its combination with RKER-050, as potential treatment options for anemia of inflammation.
  • Of these patients, 37 had completed at least 24 weeks of treatment or discontinued as of the data cut-off date (the “evaluated RP2D patients”).
  • Data for hematological response and markers of hematopoiesis were presented from exploratory analyses of these evaluated RP2D patients.
  • By targeting ALK2 inhibition to suppress hepcidin, RKER-216 increased iron availability for erythropoiesis and partially rescued anemia in CKD mice.

OpenBench and Related Sciences Launch Success-Driven Collaboration

Retrieved on: 
Tuesday, June 6, 2023
RS, Drug discovery, International Association of Students in Agricultural and Related Sciences, Science, Machine learning, SAN, Medical device, Pharmaceutical industry

SAN FRANCISCO, June 6, 2023 /PRNewswire/ -- OpenBench, Inc., a pioneer in success-driven small molecule discovery collaborations, today announced the launch of a collaboration with Related Sciences ("RS"), a data science-driven drug discovery studio, to leverage OpenBench's structure-based machine learning platform to find novel, potent chemical hit material for an initial high value RS target.

Key Points: 
  • Related Sciences expands its portfolio of drug discovery approaches with OpenBench's AI-enabled screening platform.
  • SAN FRANCISCO, June 6, 2023 /PRNewswire/ -- OpenBench, Inc., a pioneer in success-driven small molecule discovery collaborations, today announced the launch of a collaboration with Related Sciences ("RS"), a data science-driven drug discovery studio, to leverage OpenBench's structure-based machine learning platform to find novel, potent chemical hit material for an initial high value RS target.
  • Dr. Brian Albrecht, Partner and Head of Drug Discovery at Related Sciences, said "We've been extremely impressed with the scientific rigor and attractive business model that OpenBench brings to the collaboration on top of its advanced AI-driven hit finding capabilities.
  • It makes for a truly great pairing with Related Sciences' portfolio-based approach to drug discovery and our own machine learning platform for target prioritization."

RS BioTherapeutics Appoints Michelle L. Shuffett, MD as SVP of Medical and Scientific Affairs

Retrieved on: 
Monday, June 5, 2023
Children's Hospital Los Angeles, COPD, Medicine, Born This Way Foundation, University, Senior, Bureau of Oceans and International Environmental and Scientific Affairs, London, Health, Cannabinoid, Research, Child, Boehringer Ingelheim, Organization, Science, UCLA Mattel Children's Hospital, MD, Patient, RS, Hospital, Everyday Health, Rest, London School of Medicine for Women, Management, Nursing, Economics

Dr. Shuffett attended medical school at the University of Kentucky, completed her residency at UCLA Mattel Children's Hospital, and practiced at Children's Hospital Los Angeles.

Key Points: 
  • Dr. Shuffett attended medical school at the University of Kentucky, completed her residency at UCLA Mattel Children's Hospital, and practiced at Children's Hospital Los Angeles.
  • She began her career in the pharmaceutical industry at Boehringer Ingelheim, focusing on COPD opinion leader development and advocacy, medical marketing communications, research, and medical-legal review.
  • During that time, she also attended the London School of Economics and earned certifications in Healthcare Economics and Quantitative Analysis.
  • Commenting on the appointment of Dr. Shuffett, Dean Hart, Chief Executive Officer of RS BioTherapeutics said, “We are very pleased to welcome Michelle as Senior Vice President of Medical and Scientific Affairs.

Eric Schleicher, Founder and CEO of Constructive Realities Announced as Winner of OKdo's Global ROCK Engineering Challenge

Retrieved on: 
Friday, May 26, 2023
Graphics processing unit, Time of flight, Partnership, Engineering, Marketing, RS Group plc, Internet of things, Original equipment manufacturer, API, Home, CMO, Educational technology, PC, Movement, Creativity, DIY, Thermoregulation, National Association Medical Staff Services, Environmental monitoring, ROCK, Rock, Patient, Robotics, NPU terminology, RS Group, SBC, RS, Linux, Invention, Renewable energy, Entrepreneurship, AI, AR, GPU, Automation, Television, 3D printing, Health care

LONDON, May 26, 2023 /PRNewswire/ -- The ROCK Engineering Challenge invited engineers, developers, educators, inventors and entrepreneurs, to submit an idea based on the OKdo® ROCK single board computers (SBC) and compute modules. The contest attracted 160 high-quality entries from around the world, with applications and ideas spanning various verticals such as IoT, Healthcare, Smart Homes, AI, Robotics, EdTech, Renewable Energy, and Smart City initiatives.

Key Points: 
  • The grand prize winner of the ROCK Engineering challenge is Eric Schleicher and his core team at Constructive Realities .
  • Eric is developing Time of Flight (ToF) 3D cameras, capable of on-device depth data processing using the GPUs and NPUs.
  • "The ROCK Engineering Challenge has truly demonstrated the immense potential of engineers worldwide in pushing the boundaries of SBC applications.
  • "The ROCK Engineering Challenge has brought together some of the best minds to drive innovation and push the boundaries of what's possible with single board computers.

Exact Sciences Presents New Long-Term Patient Outcomes in Multi-Cancer Early Detection and Breast Cancer Recurrence Testing at ASCO® 2023

Retrieved on: 
Friday, May 26, 2023
IDC, Survivor, Abstract, American Society of Clinical Oncology, CMS, Cancer, Oncotype (Denmark), Exact sciences, ASCO, Incidence, Medicine, MD, Patient, Colorectal cancer, Risk, Lymph, Blood, Surveillance, Annual general meeting, RS, SEER, Science, Mortality, Exact Sciences (company), Recurrence, Society, Invasive carcinoma of no special type, Breast cancer, Disease, ILC, Medical imaging, Liquor, Pharmaceutical industry, Epidemiology

"These first-ever, long-term MCED follow-up data confirm Exact Sciences' approach to detecting multiple cancers at earlier stages of disease, and show that early detection enables successful treatment and long-term freedom from cancer in patients," said Tom Beer, MD, Chief Medical Officer, Multi-Cancer Early Detection, Exact Sciences.

Key Points: 
  • "These first-ever, long-term MCED follow-up data confirm Exact Sciences' approach to detecting multiple cancers at earlier stages of disease, and show that early detection enables successful treatment and long-term freedom from cancer in patients," said Tom Beer, MD, Chief Medical Officer, Multi-Cancer Early Detection, Exact Sciences.
  • In addition, Exact Sciences will present a new, long-term Surveillance, Epidemiology, and End Results (SEER) analysis showing that the Oncotype DX Breast Recurrence Score® test is prognostic for breast cancer-specific mortality (BCSM) in patients with invasive ductal carcinoma (IDC) and invasive lobular breast cancer (ILC).
  • The Oncotype DX Breast Recurrence Score test is a prognostic genomic test designed to predict the likelihood of disease recurrence and chemotherapy benefit for patients with early-stage breast cancer, which Exact Sciences clinically validated in the TAILORx and RxPONDER trials.
  • Abstract #e22508 (E-pub): A flexible quantitative framework to assess the potential contribution of early cancer detection to improved cancer survival.

RS Adds Three New Suppliers With Solutions for the Industrial, Infrastructure, Energy, and Transportation Markets

Retrieved on: 
Thursday, May 25, 2023
ExxonMobil, LSE, Eaton, Education, GE, Microsoft, NPO 2, Research, HMI, Amazon, Renewable energy, Motion, RS Group, Engineering, Mining, RS, Schneider Electric, Rockwell Automation, Knowledge, RS Group plc, Tesla, Transport, PROFIBUS, 3D printing, Transformer

FORT WORTH, Texas, May 25, 2023 /PRNewswire/ -- RS, a trading brand of RS Group plc (LSE: RS1), a global omni-channel provider of industrial product and service solutions, is proud to announce three new suppliers: Niryo, HELUKABEL, and MGM Transformer Company.

Key Points: 
  • RS is proud to announce three new suppliers: Niryo, HELUKABEL, and MGM Transformer Company.
  • The full line of Niryo solutions will soon be in stock at RS.
  • RS currently offers solutions, including PROFIBUS, TRAYCONTROL, FIVENORM, HELUKAT, HELUTHERM, TOPFLEX, TOPSERV, and HO1N2-D arc welding cables.
  • To learn more about these suppliers and their products, please contact your local RS representative at 1.866.433.5722 or reach out to our technical support team .

RS Pure™ Fine Jewelry Brand Launches The #Authentic100 Campaign Featuring Actress Brianne Howey

Retrieved on: 
Tuesday, May 23, 2023
Ginny & Georgia, RS, Pure, Personality, Jewellery, Personalized marketing, Gold, Social media, Netflix, Collection, Marketing, Fashion design

#Authentic100 is the new personal-style-focused marketing campaign, headlined by actress Brianne Howey.

Key Points: 
  • #Authentic100 is the new personal-style-focused marketing campaign, headlined by actress Brianne Howey.
  • The campaign will focus on the core values of RS Pure: authenticity, quality and craftsmanship.
  • "Brianne Howey embodies the style that RS Pure is known for," said the company's CEO, Jim Speltz.
  • The RS Pure #Authentic100 campaign is an exciting step forward for the company, as they continue to expand their reach into ecommerce and promote quality fine jewelry.

RS Offers Red Lion's New N-Tron Series NT5000 Gigabit Managed Layer 2 Industrial Ethernet Switches

Retrieved on: 
Monday, May 22, 2023
VLAN, Product management, LSE, Food, Light-emitting diode, Red Lion, Vibration, Shock, Temperature, SFP, Organization, LED, MAC, SSH, HTTPS, Red Lion Hotels, RS Group, Water, RS, RS Group plc, Copper, ESD, Robotics, SSL, RADIUS, Video game, Instrumentation

FORT WORTH, Texas, May 22, 2023 /PRNewswire/ -- RS, a trading brand of RS Group plc (LSE: RS1), a global omni-channel provider of industrial product and service solutions, is proud to offer Red Lion's new N-Tron Series NT5000 gigabit managed Layer 2 Industrial Ethernet switches, which help maximize operating performance and uptime in harsh industrial applications.

Key Points: 
  • FORT WORTH, Texas, May 22, 2023 /PRNewswire/ -- RS , a trading brand of RS Group plc (LSE: RS1), a global omni-channel provider of industrial product and service solutions, is proud to offer Red Lion's new N-Tron Series NT5000 gigabit managed Layer 2 Industrial Ethernet switches, which help maximize operating performance and uptime in harsh industrial applications.
  • NT5000 switches are engineered for ease of use, security, & durability & keep industrial networks connected & protected.
  • Red Lion's new N-Tron Series NT5000 gigabit managed Ethernet switches are engineered for ease of use, security, and durability and ideally suited for use in the factory automation, robotics, food and beverage, oil and gas, alternative energy, water and wastewater, marine, and rail industries.
  • "So, we're very pleased to offer our new N-Tron Series NT5000 gigabit managed Layer 2 Industrial Ethernet switches through RS.

Tarkett Demonstrates Power of Collaborative Creativity at Design Days 2023

Retrieved on: 
Wednesday, May 17, 2023
Science, Science Based Targets initiative, Asthma, American University, Health and Community Services Union, LVT, Culture, Research, Recycling, Targets, Assistant, Creativity, Campus Life, Fulton Fish Market, Collection, Merchandise Mart, RS, Social equity, E-mart, Neoconservatism, Transport, Environment, Nightclub, Industrial design, Interior design, Management, Creative industries, Online shopping, Collaboration

SOLON, Ohio, May 17, 2023 /PRNewswire/ -- Chicago's Fulton Market District will soon be buzzing with creative energy as more than 40,000 people from across the global design community gather in the city June 12-14 for Design Days, an annual showcase of the latest in commercial products and design. As part of the event, Tarkett, a worldwide leader in innovative and sustainable flooring solutions, will welcome design professionals into its Chicago Fulton Market showroom at 215 N. Peoria Street, Floor 10, for a firsthand look at how the company is redefining its approach to design.

Key Points: 
  • It was this process of coming together as individuals to build and create that inspired Tarkett's Collaborative collection, which will be introduced at Design Days.
  • The new collection emerged from a collaborative mark-making process led by Tarkett's vice president of design for its commercial business, Omoleye Simmons, who joined the company in September.
  • Attendees will participate in a series of hands-on exercises that reflect the process Tarkett's design team used when developing the Collaborative collection, and participants will receive a canvas featuring art created by Tarkett designers during their own collaborative design explorations.
  • For more information on Tarkett and its Design Days activities, visit contract.tarkett.com/colab .